Trial intelligence / Profile preview

Intranasal Oxytocin on Emotion Regulation

NCT03055546Phase 1Unknown

Sponsor
University of Electronic Science and Technology of China
Start
Feb 2016
Primary completion
Dec 2018
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of oxytocin nasal spray (2 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoint: Oxytocin effects on neural activity during emotion regulation task. Status: unknown.

02

Drugs

oxytocin nasal spray

Beyond the preview

Go deeper on NCT03055546.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03055546.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call